Short term monotherapy with GLP-1 receptor agonist liraglutide or PDE 4 inhibitor roflumilast is superior to metformin in weight loss in obese PCOS women: a pilot randomized study
Crossref DOI link: https://doi.org/10.1186/s13048-015-0161-3
Published Online: 2015-06-02
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Jensterle, Mojca
Salamun, Vesna
Kocjan, Tomaz
Vrtacnik Bokal, Eda
Janez, Andrej
License valid from 2015-06-02
Article History
Received: 15 January 2015
Accepted: 21 May 2015
First Online: 2 June 2015